Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Kymera Therapeutics Inc (NASDAQ: KYMR) closed the day trading at $27.37 down -7.60% from the previous closing price of $29.62. In other words, the price has decreased by -$7.60 from its previous closing price. On the day, 1.0 million shares were traded. KYMR stock price reached its highest trading level at $28.75 during the session, while it also had its lowest trading level at $26.99.
Ratios:
For a better understanding of KYMR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.53 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $52.
On December 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $60.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $55.BMO Capital Markets initiated its Market Perform rating on December 06, 2024, with a $55 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when Chiniara Ellen sold 2,241 shares for $30.45 per share. The transaction valued at 68,239 led to the insider holds 80,085 shares of the business.
Chadwick Jeremy G sold 1,383 shares of KYMR for $42,113 on Mar 03 ’25. The Chief Operating Officer now owns 67,800 shares after completing the transaction at $30.45 per share. On Mar 03 ’25, another insider, Jacobs Bruce N., who serves as the Chief Financial Officer of the company, sold 7,035 shares for $30.45 each. As a result, the insider received 214,219 and left with 201,886 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 1923645824 and an Enterprise Value of 1376537984. For the stock, the TTM Price-to-Sale (P/S) ratio is 37.76 while its Price-to-Book (P/B) ratio in mrq is 2.13. Its current Enterprise Value per Revenue stands at 29.243 whereas that against EBITDA is -5.49.
Stock Price History:
The Beta on a monthly basis for KYMR is 2.18, which has changed by -0.272848 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $29.07. The 50-Day Moving Average of the stock is -23.29%, while the 200-Day Moving Average is calculated to be -33.93%.
Shares Statistics:
Over the past 3-months, KYMR traded about 574.53K shares per day on average, while over the past 10 days, KYMR traded about 551360 shares per day. A total of 64.89M shares are outstanding, with a floating share count of 53.96M. Insiders hold about 16.91% of the company’s shares, while institutions hold 95.06% stake in the company. Shares short for KYMR as of 1741910400 were 7842166 with a Short Ratio of 13.65, compared to 1739491200 on 7339095. Therefore, it implies a Short% of Shares Outstanding of 7842166 and a Short% of Float of 13.48.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
